Directors and Advisors
Mike Salter, Chief Executive Officer
Mike Salter was appointed CEO on 1st October 2021. Previously Mike was the President of EKF Diagnostics' American business where he was responsible for all USA facilities. Previously, Mike worked at GE Healthcare where he was General Manager for the Custom Molecular Reagent Business within GE Life Sciences. Mike has over 35 years of experience in the Life Science and Diagnostics Industry, 33 of which were spent with GE and Amersham in a variety of positions in the UK, Canada and USA.
Marc Davies, Chief Financial Officer
Marc is an accomplished finance professional with over 20 years’ experience in advisory and industry settings, which include significant healthcare and capital markets experience. Before joining EKF, Marc was Group Finance and Operations Director at Flexicare Medical where he was responsible for overseeing substantial revenue growth, driven by both organic performance and acquisition. Previously Marc was a Corporate Finance Director at PwC and before that worked in AIM focussed Corporate Advisory, spending four years at WH Ireland. Marc began his career as part of the PwC Corporate Recovery team. Marc is a Fellow Chartered Accountant (FCA) and an Oxford graduate with an MSc (Distinction) in Mathematical Modelling and Scientific Computation and an MA (First Class) in Mathematical Science.
Christopher Mills, Non-Executive Chairman
Christopher founded Harwood Capital Management in 2011, a successor to its former parent company J.O. Hambro Capital Management, which he co-founded in 1993. He is Chief Executive and Investment Manager of North Atlantic Smaller Companies Investment Trust plc and Chief Investment Officer of Harwood Capital LLP. He is a Non-Executive Director of a number of companies including Renalytix AI plc. Christopher was a Director of Invesco MIM, where he was Head of North American Investments and Venture Capital, and of Samuel Montagu International. Christopher is a member of the Audit Committee and the Remuneration Committee.
Julian Baines, Deputy Non-Executive Chairman
Julian is currently Non-Executive Chairman of Trellus Health plc and Verici Dx plc, as well as being Deputy Non-Executive Chairman of EKF Diagnostics Holdings plc. Julian has significant experience in the life science industry. He has over 20 years' experience as CEO of EKF Diagnostics Holdings plc and BBI Holdings plc. Before joining EKF, he undertook a management buyout at BBI in 2000, a flotation on AIM in 2004 and was responsible for selling the business to Alere Inc. (now part of Abbott Laboratories) in 2008 for c. £85 million. At EKF he successfully completed a number of fund raisings, acquisitions and subsequent integration of businesses in seven countries. He oversaw the spin out of businesses from EKF including Renalytix plc which listed on Nasdaq in 2020. In 2016 he was awarded an MBE (Member of the British Empire) for services to the life sciences industry. Julian has previously held the position of Non-Executive Chairman of Renalytix Plc between 2018 and 2020.
Christian Rigg, Non-Executive Director
Chris Rigg has significant executive experience at both public and private companies. He is currently the Chief Executive Officer of Mandata Holdings Limited and a Non-Executive Director of the main market listed Sportech plc. Chris previously held the positions of Chief Financial Officer and latterly Chief Executive Officer at Quantum Pharma plc, which, under his stewardship, was refinanced and implemented a new strategy facilitating growth and leading to its acquisition by Clinigen Group plc for an enterprise value of £160 million.
Jenny Winter, Non-Executive Director
Jenny has over 20 years’ experience across a broad variety of healthcare organisations ranging from small not-for-profit companies to large corporates. Jenny is currently Chief Executive Officer of AIM listed Animalcare Group plc (AIM: ANCR) where she is successfully executing on the business’s long-term growth strategy, as reflected in the recently announced strong full year trading performance against a backdrop of very challenging market conditions. Jenny has a science-led career spanning R&D, clinical research, strategic product development and commercial growth across various aspects of the healthcare industry. Before joining Animalcare Group plc in October 2018, Jenny was Vice President of Respiratory products – Global Supply Chain and Strategy at AstraZeneca, a position she held from 2015. Other roles at AstraZeneca included Vice President Cardiology – Global Product and Portfolio Strategy, Commercial Director – Eastern Europe, Marketing Company President Hungary, where she led a major change programme to drive future success, and Global Vice President, Group Public Affairs. Jenny has also been CEO of the charity Barretstown, transforming it into a successful leading charity which provides therapeutic recreation programmes for children and their families affected by serious illness, as well as virtual school and hospital outreach activities. Her work at the charity resulted in her being invited by Barretstown board member Dermot Gleeson, Chairman of Allied Irish Bank, to join the Board of the bank as a Non-executive Director, a role she held from 2004 to 2010. Jenny is also Chairman of a charity – Royal Brompton and Harefield Hospital Charity, an NHS charity supporting the local hospitals.
Jenny has a BSc in Physiology and Pharmacology from the University of Southampton.
Nominated Advisor and Joint Broker
Singer Capital Markets
1 Bartholomew Lane
Investec Bank plc
30 Gresham Street
97 Bute Street
Financial PR & Investor Relations
Walbrook PR Limited
75 King William Street,
29 Wellington Street
Salim Hamir FCA